Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference

Study highlights potential benefit in rare pediatric orthopedic disorder Mont-Saint-Guibert, Belgium, October 2, 2019: Novadip Biosciences (“Novadip” or “the company”), a ...

Novadip Biosciences presents data at 11th annual “THE BIOPROCESSING SUMMIT”, Boston, MA.

Nicolas Theys1, Gaëtan Thirion1, Sophie Vériter1, Valérie Lebrun1, Pierre-Yves Adnet1, Céline Caty1, Ali Modarressi2, Denis Dufrane1 1Novadip Biosciences, Mont Saint Guibert, Belgium ...

Novadip Biosciences presents data at 30th annual EURAPS Research Council Meeting

Data demonstrates safety and efficacy of allogenic 3D scaffold-free tissue engineered product for deep thickness skin regeneration Mont-Saint Guibert, Belgium, 23 May 2019: Novadip Biosciences ...

L'Echo : Les Belges présents en force à la plus grande bourse biotech du globe

Lien vers l'article : Les Belges présents en force à la plus grande bourse biotech du globe

L’Echo : Atelier plasticine

Pour reconstruire le tissu osseux, Novadip Biosciences a mis au point un genre de plasticine faite à partir des cellules souches du patient. Ultra pratique pour le chirurgie, ultra pratique pour ...

Critical size bone defect reconstruction by an autologous 3D osteogenic-like tissue derived from differentiated adipose MSCs

For critical size bone defects and bone non-unions, bone tissue engineering using osteoblastic differentiated adipose mesenchymal stem cells (AMSCs) is limited by the need for a biomaterial to ...

The enhanced performance of bone allografts using osteogenic-differentiated adipose-derived mesenchymal stem cells

Adipose tissue was only recently considered as a potential source of mesenchymal stem cells (MSCs) for bone tissue engineering. To improve the osteogenicity of acellular bone allografts, adipose ...